ARTICLE | Company News
Myriad Genetics, Rules-Based deal
June 6, 2011 7:00 AM UTC
Diagnostic company Myriad completed its previously announced acquisition of Rules-Based Medicine for about $80 million in cash. Rules-Based Medicine became a wholly-owned subsidiary of Myriad and will...